Literature DB >> 7714941

A community-based evaluation of eyesight and spectacle use after intracapsular cataract extraction in northern India.

G V Murthy1, S K Gupta.   

Abstract

The visual outcome and extent of aphakic spectacle use at community level was evaluated in 177 patients who underwent ICCE in peripheral camps. In 16.9%, both eyes were operated. The mean age at cataract surgery was 63 years (range 33-82 years). After surgery, 79.7% had better vision; 72.3% were extremely satisfied with the surgical outcome. Of those with improved or similar vision, 81.9% were regularly using aphakic spectacles. Free aphakic spectacles after surgery were received by 57.6%. Broken spectacles was the most common cause for not using or intermittently using spectacles. The major benefits to patients were the ability to undertake personal activities, improved mobility and recognition of family members, friends and cattle.

Entities:  

Mesh:

Year:  1995        PMID: 7714941

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  6 in total

Review 1.  Prevention strategies for age related cataract: present limitations and future possibilities.

Authors:  N G Congdon
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

2.  Visual outcome of the first 500 cataract extractions done in the field; Jimma, Ethiopia.

Authors:  N Zerihun
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  The south Asian cataract management study.

Authors:  A F Smith
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

4.  Peters' anomaly.

Authors:  T Jordan
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

5.  Visual outcomes after cataract surgery and cataract surgical coverage in India.

Authors:  D Bachani; S K Gupta; G V Murthy; R Jose
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

6.  Longitudinal study on visual outcome and spectacle use after intracapsular cataract extraction in northern India.

Authors:  Sanjeev K Gupta; G V S Murthy; Namrata Sharma
Journal:  BMC Ophthalmol       Date:  2003-07-28       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.